ChromaCode Launches High-Throughput HDPCR SARS-CoV-2 Assay
The covid-19 assay has been validated by ChromaCode, and an independent review of the validation data by FDA is pending.
Read MorePosted by | Apr 27, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The covid-19 assay has been validated by ChromaCode, and an independent review of the validation data by FDA is pending.
Read MorePosted by | Apr 27, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The project aims to facilitate early diagnosis and support efforts to stop the Ebola virus disease epidemic.
Read MorePosted by | Apr 24, 2020 | Covid 19, Infectious Diseases, Research |
Phase II drug trials systematically overestimate the efficacy of therapeutics, so that subsequent phase III trials often produce disappointing results.
Read MorePosted by Steve Halasey | Apr 23, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
It is time to rally around nursing home and assisted-living residents the same way we have around hospital patients and workers.
Read MorePosted by | Apr 22, 2020 | Controls, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Quality Systems |
The Qnostics SARS-CoV-2 Medium Q control is designed to ensure the accuracy and reliability of molecular assays used in diagnostic testing for covid-19.
Read More